-
CD Genomics Announces Advanced CDAMP® Panel Kits for SARS-CoV-2 Detection
Aug 10, 2020, 03:33 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Aug 12, 2020 - CD Genomics, an internationally leading provider of microbial testing services, microbial genomics services, and integrated bioinformatics services for hospitals, food, diagnostics, pharma, agriculture, biotechnology, and research institutes, announces advanced CDAMP® Panel Kits for SARS-CoV-2 detectionFull story -
Creative Proteomics Introduces Advanced Gut Metatranscriptome Analysis Solutions
Aug 10, 2020, 03:28 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Aug 10, 2020 - Creative Proteomics, an integrated CRO company committed to providing oncology multi-omics research services and personalized custom oncology research services, has recently launched its fully-developed gut metatranscriptome analysis solutions for the identification of key genes and gut physiology monitoring, as well as clinical diagnosis and screening for drug targets or for genes, enzymes and metabolites relevant for human healthFull story -
Creative Enzymes Optimizes Screening of Enzyme Activators for Enzyme Profiling
Aug 10, 2020, 03:19 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Aug 10, 2020 - Creative Enzymes, an excellent supplier and manufacturer located in New York, always hammers at researches and trials in order to provide customers with various enzymes as many as possibleFull story -
Researchers Using Models To Understand COVID-19, Other News
Aug 7, 2020, 09:28 AM by User Not FoundBio-IT World | Researchers are continuing to analyze COVID-19 through several models. A new mouse model is being developed in China to test and confirm the efficacy of a potential vaccine, while a researcher in the US is using computer models to understand the structure of the virus.Full story -
Kyruus Recruits Jamie Kiggen as its New Chief Financial Officer
Aug 6, 2020, 10:42 AM by Michael CroftBOSTON, MA, UNITED STATES - Aug 6, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Jamie Kiggen has joined its executive leadership team as Chief Financial OfficerFull story -
Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite
Aug 6, 2020, 10:25 AM by Michael CroftCONNECTICUT, CT, UNITED STATES - Aug 6, 2020 - Phesi, a data-driven provider of clinical development analytics products and solutions, today announced a new country selection functionality has been added to ClinSite, its platform to provide investigator site intelligence to clients, enabling investigator site selection and managementFull story -
Time to Innovate for Faster, Smarter Discovery and Clinical Development Cycles
Aug 6, 2020, 08:24 AM by User Not FoundBio-IT World Contributed Commentary | We’ve learned so much living through these unprecedented times. One lesson is the need to mobilize quickly, provide effective testing and contact tracing, and accelerate the development of therapies and vaccines to protect the global community. That can only be done through the power of data: the defining currency in drug discovery and clinical development.Full story -
Over 300 Clinical Studies Benefit from CluePoints COVID-19 Risk Management Support
Aug 6, 2020, 08:10 AM by Michael CroftKING OF PRUSSIA, PA - Aug 6, 2020 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trialsFull story -
Raremark® launches the Xperiome™ patient-powered knowledge platform to deliver new therapies faster and smarter
Aug 6, 2020, 08:04 AM by Michael CroftLONDON, UK - Aug 6, 2020 - Raremark®, the leading online patient community in rare disease, has today launched its patient-powered knowledge platform Xperiome to help the pharmaceutical industry deliver innovative new therapies faster and smarterFull story -
Follow the Money: Cash for AI Models, Oncology, Hematology Therapies
Aug 5, 2020, 15:10 PM by Michael CroftBio-IT World Sema4 gets $121M to build dynamic models of human health and define optimal, individualized health trajectories. Glioblastoma, hematology, and acute pancreatitis all see new funding for therapy development. And AI-powered models net cash.Full story -
Ancestry Launches NGS Tests With Family History Component
Aug 4, 2020, 07:50 AM by Michael CroftFull storyBio-IT World | Ancestry has launched AncestryHealth powered by Next Generation Sequencing. It is an upgrade to AncestryDNA + Traits, adding genetic health risk reports, a family health history tool, and other resources.
-
Panthera’s UK oncology clinical trial sites open for studies
Aug 3, 2020, 14:16 PM by Michael CroftPRESTON, UNITED KINGDOM - Aug 3, 2020 -Full story- More than 1000 International Cancer Trials Suspended Due to COVID-19
- Panthera working with the state of the art Rutherford Cancer Centres across the UK is open for clinical research activities including screening
-
Sterling Signs Deal to Produce Potential COVID-19 Drug Candidate for Moleculin
Aug 3, 2020, 13:46 PM by Michael CroftCRAMLINGTON, UNITED KINGDOM - Jul 27, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has signed an agreement with Moleculin Biotech, IncFull story -
Abzena appoints Matthew LeClair as SVP and Site Head of San Diego Operations
Aug 3, 2020, 13:44 PM by Michael CroftSAN DIEGO, CA, UNITED KINGDOM - Aug 3, 2020 - Cambridge, UK and San Diego, CA, 3 August 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Matthew LeClair as Senior Vice President (SVP) and Site Head of its San Diego OperationsFull story -
SkinCheck affordable skin cancer screening re-opens
Aug 3, 2020, 10:11 AM by Michael CroftCAMBRIDGE, UK - Aug 3, 2020 - Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, is reopening its SkinHealth SkinCheck clinics following enforced closure due to COVID-19Full story -
One Small Step For Open Science, One Giant Leap For Metastasis Research
Aug 3, 2020, 08:40 AM by Michael CroftFull storyBio-IT World | In a first-of-its-kind collaboration, researchers from 19 academically affiliated international laboratories have agreed to share their cell line models specific to brain metastasis with pretty much anyone who asks for them.
-
LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy
Aug 3, 2020, 07:00 AM by Michael CroftAMSTERDAM, THE NETHERLANDS - Aug 3, 2020 - LUMICKS has entered into a collaboration with Glycostem Therapeutics, the Netherlands, to improve immunotherapeutic drug developmentFull story -
Creative Peptides Provides Synthetic Peptides for Developing Vaccines
Aug 3, 2020, 05:05 AM by Michael CroftSHIRLEY, NY - Aug 3, 2020 - In the current COVID-19 pandemic, synthetic peptides play an important role in vaccine development. Creative Peptides, a supplier mainly engaged in the production of biologically active peptides, recently announced that it can provide synthetic peptides for vaccine developmentFull story -
Alfa Chemistry Materials—a New Option of Material Building Blocks
Aug 1, 2020, 01:55 AM by Michael CroftNY, NY - Aug 1, 2020 - Material building blocks are of vital importance in various areas such as in the production of semiconductorsFull story -
New Data on Genetic Expression In Severe COVID-19, Pre-Existing Immune Response
Jul 31, 2020, 08:35 AM by Michael CroftFull storyBio-IT World | Research continues to uncover the underlying biology of SARS-CoV-2 and reveal some surprises. A German team found that 35% of their healthy controls had pre-existing SARS-CoV-2 cross-reactive T cells, and several groups are narrowing down the gene expression signatures that might explain why COVID-19 is so severe in some patients.